Manufacturers Life Insurance Company, The Summit Therapeutics Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 295,629 shares of SMMT stock, worth $6.91 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
295,629
Previous 206,057
43.47%
Holding current value
$6.91 Million
Previous $1.61 Million
302.86%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding SMMT
# of Institutions
198Shares Held
75.9MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$571 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$256 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$185 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$127 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$81.1 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.71B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...